$CELZ near 52 week low! Tight OS and FLOAT. Stem Cell tech rolled out First Quarter 2018, huge revenues expected soon. Last PR showed new Subsidiary that will create Stem Cell tech for brain injuries and neurodegenerative diseases.
52-Wk Range
0.0021 - 0.70
Trading @ .0027
Share Structure Information As Of 3-2-18
Authorized Shares - 3,000,000,000
Outstanding Shares - 233,571,295
Creative Medical Technology Holdings, Inc. Announces Formation of CerebroStem LLC
Feb 20 18
Creative Medical Technology Holdings, Inc. announced the formation of CerebroStem LLC, a majority owned subsidiary focused on developing stem cell therapies for brain injuries and neurodegenerative diseases. The company's initial focus will be treating radiation induced brain damage, a major cause of cognitive dysfunction in patients with brain cancer who have received radiation therapy. In addition to treating radiation induced brain damage, CerebroStem LLC plans to pursue other areas of brain degeneration including stroke, multiple sclerosis, and Parkinson's Disease.